Bartonellosis medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 55: Line 55:
:::*Preferred regimen : [[Erythromycin]] 500 mg PO qid {{or}} [[Doxycycline]] 100mg PO bid for >3 months.
:::*Preferred regimen : [[Erythromycin]] 500 mg PO qid {{or}} [[Doxycycline]] 100mg PO bid for >3 months.
::* '''4.Peliosis hepatitis'''
::* '''4.Peliosis hepatitis'''
::::*Preferred regimen : [[Erythromycin]] 500 mg PO qid {{or}} [[Doxycycline]] 100 mg PO bid for 4 months.
:::*Preferred regimen : [[Erythromycin]] 500 mg PO qid {{or}} [[Doxycycline]] 100 mg PO bid for 4 months.
:::*'''5.Oroya fever'''
::* '''5.Oroya fever'''
::::*Preferred regimen : [[Ciprofloxacin]] 500 mg PO bid for 10 days.
:::*Preferred regimen : [[Ciprofloxacin]] 500 mg PO bid for 10 days.
:::*'''6.Endocarditis'''
::* '''6.Endocarditis'''
::::*Preferred regimen : [[Gentamicin]] 3 mg/kg/day IV q8h for 14 days {{and}} [[Ceftriaxone]] 2 g/day IV for 6 weeks with or without [[Doxycycline]] 100 mg PO bid for 6 weeks.
:::*Preferred regimen : [[Gentamicin]] 3 mg/kg/day IV q8h for 14 days {{and}} [[Ceftriaxone]] 2 g/day IV for 6 weeks with or without [[Doxycycline]] 100 mg PO bid for 6 weeks.


==References==
==References==

Revision as of 19:35, 9 July 2015

Bartonellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bartonellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bartonellosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bartonellosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bartonellosis medical therapy

CDC on Bartonellosis medical therapy

Bartonellosis medical therapy in the news

Blogs on Bartonellosis medical therapy

Directions to Hospitals Treating Bartonellosis

Risk calculators and risk factors for Bartonellosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Pharmacotherapy

Treatment of infections caused by Bartonella species.[1][2]

Disease Adults Children
Cat scratch disease no recommendation no recommendation
Retinitis Doxycycline + Rifampin unknown
Trench fever or chronic bacteremia by B.quintana Doxycycline + Gentamicin unknown
Bacillary angiomatosis Erythromycin or Doxycycline Erythromycin
Peliosis hepatis Erythromycin or Doxycycline Erythromycin
Endocarditis Doxycycline + Gentamicin + Rifampin or Ceftriaxone + Gentamicin
Carrión´s disease (acute phase) Ciprofloxacin or Chloramphenicol Chloramphenicol + beta-lactam
Carrión´s disease (chronic phase: Verruga peruana) Rifampin or macrolides Rifampin or macrolides

Anti microbial regimen

  • Bartonellosis[3]
  • 1.Cat scratch disease
  • 1.1.If extensive adenopathy
  • 2.Retinitis
  • 3.Bacillary angiomatosis
  • 4.Peliosis hepatitis
  • 5.Oroya fever
  • 6.Endocarditis

References

  1. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D (2004). "Recommendations for treatment of human infections caused by Bartonella species". Antimicrob. Agents Chemother. 48 (6): 1921–33. doi:10.1128/AAC.48.6.1921-1933.2004. PMC 415619. PMID 15155180. Unknown parameter |month= ignored (help)
  2. Blanco JR, Raoult D (2005). "[Diseases produced by Bartonella]". Enferm. Infecc. Microbiol. Clin. (in Spanish; Castilian). 23 (5): 313–9, quiz 320. PMID 15899181. Unknown parameter |month= ignored (help)
  3. Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.

Template:WikiDoc Sources